Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy L Silverstein

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Cell Biology|October 31, 2002
The face of TSR revealed: an extracellular signaling domain is exposedRoy L Silverstein
The Journal of Clinical Investigation|August 19, 2025
Chronic diseases alter the platelet rheostat to promote hyperreactivity and thrombosisRoy L Silverstein
Circulation|December 30, 2020
PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP"Roy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2025
Just Say NO to CD36 Expression: A Regulatory Pathway With Implications in Many Chronic DiseasesRoy L Silverstein
Blood Advances|November 14, 2025
FcR γ-chain and platelet hyperactivityRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|December 29, 2017
Oxidized Lipid Uptake by Scavenger Receptor CD36 (Cluster of Differentiation 36) Modulates Endothelial Surface Properties and May Contribute to AtherogenesisRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2016
Metabolic Manipulation to Put the Brakes on Platelet Activation: A Potential Novel Pharmacologic Approach to AtherothrombosisRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2014
Platelet CD36 links not only α-granule-derived proteins to thrombus stability but also metabolic and oxidant stress to a prothrombotic phenotypeRoy L Silverstein
The Journal of Clinical Investigation|January 5, 2012
Teaching an old dog new tricks: potential antiatherothrombotic use for statinsRoy L Silverstein
Blood|April 25, 2015
Disabling the platelet's brakes to promote thrombosisRoy L Silverstein
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Cell Biology|October 31, 2002
The face of TSR revealed: an extracellular signaling domain is exposedRoy L Silverstein
The Journal of Clinical Investigation|August 19, 2025
Chronic diseases alter the platelet rheostat to promote hyperreactivity and thrombosisRoy L Silverstein
Circulation|December 30, 2020
PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP"Roy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2025
Just Say NO to CD36 Expression: A Regulatory Pathway With Implications in Many Chronic DiseasesRoy L Silverstein
Blood Advances|November 14, 2025
FcR γ-chain and platelet hyperactivityRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|December 29, 2017
Oxidized Lipid Uptake by Scavenger Receptor CD36 (Cluster of Differentiation 36) Modulates Endothelial Surface Properties and May Contribute to AtherogenesisRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2016
Metabolic Manipulation to Put the Brakes on Platelet Activation: A Potential Novel Pharmacologic Approach to AtherothrombosisRoy L Silverstein
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2014
Platelet CD36 links not only α-granule-derived proteins to thrombus stability but also metabolic and oxidant stress to a prothrombotic phenotypeRoy L Silverstein
The Journal of Clinical Investigation|January 5, 2012
Teaching an old dog new tricks: potential antiatherothrombotic use for statinsRoy L Silverstein
Blood|April 25, 2015
Disabling the platelet's brakes to promote thrombosisRoy L Silverstein
Pageof 11